Keywords: Pfizer, Eisai, Aricept, Lyrica, Licensing

Pfizer and Eisai continue Aricept collaboration; to co-promote Lyrica in Japan

Article | 25 September 2009

Print This

Global drugs behemoth Pfizer says that its agreement with Japan’s Eisai to provide Aricept (donepezil) to patients suffering from ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in